NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study. This prospective interventional randomized study included healthy individuals without a history of dry eye disease.

EvoTears replaces the outer layer of the tear film to form a shield and protect the tear film from evaporating. This allows EvoTears to replace the function of the lipid layer, forming an outer shield over the surface of the tear film, reducing evaporation of the watery layer.For many patients, the road to finding a satisfactory therapy with an artificial tear substitute or moisturizer is difficult.

Esta cookie permite conservar abiertas las sesiones del usuario durante su visita y le permite pasar un pedido o toda una serie de funcionamientos como: fecha de adición de la cookie, idioma seleccionado, divisa utilizada, última categoría de producto visitado, productos recientemente vistos, acuerdo de utilización de servicios del sitio, identificador del cliente, identificador de conexión, apellido, nombre, estado conectado, su contraseña cifrada, e-mail relacionado con la cuenta del cliente y el identificador del carrito. The purpose of this prospective, controlled clinical study was to evaluate the effect of a non-aqueous liquid, perfluorohexyloctane (F6H8; Evotears®), on HOA after four weeks of application in otherwise healthy subjects. EvoTears ® spreads very quickly and rapidly forms a protective layer over the tear to counteract premature evaporation. Dry eyes are one of the most common eye diseases; it is estimated that one in every 6 adults in Germany is affected by it. The mean pre- and post-interventional values for the aberrometric indices and the 95% LoR for the first 100 eyes are tabulated (Table ​ (Table2).

Keep holding the bottle upside down, gently pull down your lower eyelid, and place the dropper tip above the eye.